Delivery Order SPE2DB22D1017-SPE2DB25FYPVE
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pens in 0.5 mL quantities, with a ceiling value of $8,408.08. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 2, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a firm fixed price delivery order valued at $17,749.40 for Zepbound 2.5 mg/0.5 ml pens with a completion date of July 14, 2025. This competitively awarded, non-set-aside contract represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply vehicle with DLA. The product will be performed at the vendor's Conshohocken, Pennsylvania location, which serves as the company's corporate headquarters and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $41,202.03 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pens on August 21, 2025, with an ultimate completion date of August 22, 2025. This non-competitive, firm fixed-price delivery order is being fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a critical pharmaceutical supplier to federal medical...
- The Defense Logistics Agency awarded a $1,584.34 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pens. This firm fixed-price, non-competitive delivery order is set to be completed by August 19, 2025, with performance occurring at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government's...
- The Defense Logistics Agency awarded a delivery order valued at $6,863.22 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 ml pens on July 17, 2025, with an ultimate completion date of July 18, 2025. This competitively awarded, firm fixed-price delivery order represents a single-line pharmaceutical supply transaction with no set-aside designation. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $3,050.40 to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pens. This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of August 4, 2025. The order will be fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order represents a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,955.30 to AmerisourceBergen Drug Corp for the supply of Zepbound 2.5 mg/0.5 mL pens (0.5 mL units). This firm fixed price delivery order was competitively awarded without set-aside provisions and carries an ultimate completion date of June 2, 2025. The award was made to AmerisourceBergen's Corporate Office division, with performance taking place at the company's headquarters in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,178.52 to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 mL pen injections on June 24, 2025, with completion targeted for June 25, 2025. This competitively awarded, firm fixed-price delivery order represents fulfillment under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $2,383.56 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Zepbound 12.5 mg/0.5 mL pen injections. This non-competitive delivery order, with an ultimate completion date of July 15, 2025, represents a small-value pharmaceutical transaction supporting federal medical procurement needs. The award was fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order valued at $10,160.15 to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 mL pens on August 13, 2025, with completion scheduled for August 14, 2025. This firm fixed-price contract, issued without a set-aside designation, represents a competitively awarded delivery order under AmerisourceBergen's broader pharmaceutical supply arrangement with the federal government. The product will be delivered to the company's facility in Conshohocken,...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FYPVEDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,267.84 to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 mL pens on September 3, 2025, with completion by September 4, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order issued under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor serving military and federal healthcare systems. This delivery order is issued under AmerisourceBergen's substantial $999.999 billion Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), running through December 2026. As a designated prime vendor under this comprehensive pharmaceutical support vehicle, AmerisourceBergen supplies a wide range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs globally, including services to the Defense Health Agency and U.S. Coast Guard. The company's consistent receipt of competitively awarded federal medical procurement orders demonstrates its capability to meet stringent federal supply requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 9/3/25 |